Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why ChemoCentryx Shares Are Falling

ChemoCentryx Inc (NASDAQ:CCXI) shares are trading lower by 12.8% at $25.70 Wednesday morning after the company reported worse-than-expected fourth-quarter EPS and sales results.

ChemoCentryx reported quarterly losses of 58 cents per share which missed the analyst consensus estimate of a loss of 50 cents per share. ChemoCentryx also reported quarterly sales of $2.31 million which missed the analyst consensus estimate of $11.62 million by 80%. This is a 47% decrease over sales of $4.36 million in the same period last year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.